| P2093 | author name string | Kazuhiro Suzuki | |
| | Hiromichi Hamada | |
| | Masaru Terai | |
| | Takafumi Honda | |
| | Yoichi Kohno | |
| | Tomomichi Kurosaki | |
| | Hiroaki Inomata | |
| | Hiromichi Nakajima | |
| | Kumi Yasukawa | |
| | Toshiaki Jibiki | |
| | Itaru Terashima | |
| P2860 | cites work | Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy | Q28184382 |
| | Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial | Q28196604 |
| | Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children | Q34244547 |
| | Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose | Q34452119 |
| | A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome | Q34580488 |
| | Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease | Q40584533 |
| | Corticosteroids in the treatment of the acute phase of Kawasaki disease | Q40631670 |
| | Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids | Q42557663 |
| | Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes | Q44216468 |
| | Prognostic impact of vascular leakage in acute Kawasaki disease | Q47791880 |
| | Early postnatal dexamethasone decreases hepatocyte growth factor in tracheal aspirate fluid from premature infants. | Q51702015 |
| | Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema | Q54261132 |
| | Therapeutic effects of local delivery of dexamethasone on experimental brain tumors and peritumoral brain edema | Q70506030 |
| | Kawasaki disease | Q71761805 |
| | Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness | Q77313987 |
| | Increased serum levels of vascular endothelial growth factor in Kawasaki disease | Q77417492 |
| | Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease | Q77626697 |
| P433 | issue | 4-5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Kawasaki disease | Q265936 |
| | dexamethasone | Q422252 |
| P304 | page(s) | 229-33 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | European Journal of Pediatrics | Q15755736 |
| P1476 | title | Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease | |
| P478 | volume | 163 | |